Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF,CD55) and membrane cofactor protein (MCP,CD46) on a human colonic adenocarcinoma cell line

被引:47
作者
Bjorge, L [1 ]
Jensen, TS [1 ]
Matre, R [1 ]
机构
[1] UNIV BERGEN,BROEGELMANN RES LAB MICROBIOL,N-5021 BERGEN,NORWAY
关键词
complement; CD55 (DAF); CD46 (MCP); cancer biology;
D O I
10.1007/s002620050269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To avoid destruction by complement, normal and malignant cells express membrane glycoproteins that restrict complement activity. These include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and protectin (CD59), which are all expressed on colonic adenocarcinoma cells in situ. In this study we have characterised the C3/C5 convertase regulators DAF and MCP on the human colonic adenocarcinoma cell line HT29. DAF was found to be a glycosyl-phosphatidylinositol-anchored 70-kDa glycoprotein. Blocking experiments with F(ab')2 fragments of the anti-DAF monoclonal antibody BRIC 216 showed that DAF modulates the degree of C3 deposition and mediates resistance to complement-mediated killing of the cells. The expression and function of DAF were enhanced by tumour necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL-1 beta). Cells incubated with interferon gamma (IFN gamma) did not alter their DAF expression. Two MCP forms were expressed, with molecular masses of approximately 58 kDa and 68 kDa, the lower form predominating. MCP expression was up-regulated by IL-1 beta, but not by TNF alpha or IFN gamma. Expression of DAF and MCP promotes resistance of colonic adenocarcinoma cells to complement-mediated damage, and represents a possible mechanism of tumour escape.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 39 条
[11]   TARGETED NEUTRALIZATION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX INHIBITOR CD59 ON THE SURFACE OF HUMAN-MELANOMA CELLS [J].
JUNNIKKALA, S ;
HAKULINEN, J ;
MERI, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (03) :611-615
[12]   DECAY-ACCELERATING FACTOR (DAF, CD55) IN NORMAL COLORECTAL MUCOSA, ADENOMAS AND CARCINOMAS [J].
KORETZ, K ;
BRUDERLEIN, S ;
HENNE, C ;
MOLLER, P .
BRITISH JOURNAL OF CANCER, 1992, 66 (05) :810-814
[13]   EXPRESSION OF CD59, A COMPLEMENT REGULATOR PROTEIN AND A 2ND LIGAND OF THE CD2 MOLECULE, AND CD46 IN NORMAL AND NEOPLASTIC COLORECTAL EPITHELIUM [J].
KORETZ, K ;
BRUDERLEIN, S ;
HENNE, C ;
MOLLER, P .
BRITISH JOURNAL OF CANCER, 1993, 68 (05) :926-931
[14]  
KUMAR S, 1993, CANCER RES, V53, P348
[15]  
LASS JH, 1990, INVEST OPHTH VIS SCI, V31, P1136
[16]  
LISZEWSKI MK, 1992, CURR TOP MICROBIOL, V178, P45
[17]   MEMBRANE COFACTOR PROTEIN OF COMPLEMENT IS PRESENT ON HUMAN FIBROBLAST, EPITHELIAL, AND ENDOTHELIAL-CELLS [J].
MCNEARNEY, T ;
BALLARD, L ;
SEYA, T ;
ATKINSON, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :538-545
[18]   IDENTIFICATION OF THE COMPLEMENT DECAY-ACCELERATING FACTOR (DAF) ON EPITHELIUM AND GLANDULAR CELLS AND IN BODY-FLUIDS [J].
MEDOF, ME ;
WALTER, EI ;
RUTGERS, JL ;
KNOWLES, DM ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :848-864
[19]  
MORAN P, 1992, J IMMUNOL, V149, P1736
[20]  
MORGAN BP, 1989, BIOCHEM J, V264, P1